golodirsen (Vyondys 53) Report issue

Gene therapy Orphan Drug FDA Approved FDA Fast Track FDA Accelerated Approval FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Golodirsen, sold under the brand name Vyondys 53, is a medication used for the treatment of Duchenne muscular dystrophy (DMD). It is an antisense oligonucleotide drug of phosphorodiamidate morpholino oligomer (PMO) chemistry.   Wikipedia

More Chemistry

Drug Pricing (per unit)

United States

$1222.1100 - $1591.9600
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

srp-4053

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue